GlassScriptPhysician profile
David Avino
NPI 1710944632
$6,164.95
in general payments reported to CMS, 2019-2025
10 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,242 · 2020: $1,557 · 2021: $1,389 · 2022: $762 · 2023: $650 · 2024: $405 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212 · Education: $3.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.27 |
| Education | $3.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,553.30 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Pfizer INC. | $783.92 | 2019-2025 | |
| Amgen INC. | $508.27 | 2019-2025 | Repatha, Repatha |
| Stryker Corporation | $168.20 | 2023 | Mako |
| Boston Scientific Corporation | $73.59 | 2023-2025 | Watchman Access System, Watchman |
| Janssen Pharmaceuticals, INC | $36.31 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $23.28 | 2022 | |
| Allergan, INC. | $15.00 | 2019 | |
| Travere Therapeutics, INC. | $3.08 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Avino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.